Curvo is offering a complimentary Rx Spend Opportunity Assessment to help health systems uncover potential opportunities within their existing pharmacy purchase data, including pricing, biosimilars, and 340B optimization.

Curvo is a healthcare-only supply chain data and technology company committed to aligning providers and suppliers around a shared goal: better, more valuable care for patients. Independent and GPO-agnostic, Curvo tracks nearly 40% of the U.S. healthcare market’s non-labor spend, creating a trusted source of market intelligence that clients rely on for transparent pricing across medical and pharmaceutical spend. More than an innovator, Curvo is a proven partner — combining scalable technologies with expert services from seasoned healthcare professionals who understand industry complexities and bring fresh thinking and new ways to visualize data. As the industry standard for accurate, impartial data, Curvo enables fair, fact-based decisions that help providers measure, manage and optimize cost, quality and compliance while enabling suppliers to demonstrate value and build trust. The result is an industry that can finally realize the value of a fully integrated clinical supply chain — one that benefits hospitals, clinicians, suppliers and, ultimately, patients.